New CRISPR based stem cell implant releases drug as required in arthritis
GEN News - 02-Sep-2021Reduced inflammation & bone damage in mice; relieves patients from their regular use of injections
Join the club for FREE to access the whole archive and other member benefits.
Professor of Orthopaedic Surgery at Washington University
Farshid Guilak is a Professor in the Department of Orthopaedic Surgery at Washington University and Director of Research for the Shriners Hospitals for Children – St. Louis Shriners. He is also the co-director of the Washington University Center of Regenerative Medicine and has appointments in the Departments of Developmental Biology and Biomedical Engineering. He is the editor-in-chief of the Journal of Biomechanics, Associate editor for Osteoarthritis & Cartilage, and serves on numerous other journal editorial boards. He is also the President of the Orthopaedic Research Society and Chair of the Skeletal Biology Structure and Regeneration NIH Study Section, and the first PhD member of the executive committee of the Orthopaedic Research and Education Foundation (OREF).
Visit website: https://orthopaedicresearch.wustl.edu/labs/farshid-guilak/
See also: Washington University in St. Louis - Private multidisciplinary research university.
Details last updated 08-Mar-2021
Reduced inflammation & bone damage in mice; relieves patients from their regular use of injections
Engineered cells produce anti-inflammatory drug that helps reduce stress-related cartilage damage